Cibc Private Wealth Group, LLC Biogen Inc. Transaction History
Cibc Private Wealth Group, LLC
- $51.3 Billion
- Q1 2025
A detailed history of Cibc Private Wealth Group, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 1,162 shares of BIIB stock, worth $175,973. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,162
Previous 1,384
16.04%
Holding current value
$175,973
Previous $211,000
24.64%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding BIIB
# of Institutions
1,043Shares Held
132MCall Options Held
2.84MPut Options Held
2.54M-
Vanguard Group Inc Valley Forge, PA17.3MShares$2.62 Billion0.04% of portfolio
-
Primecap Management CO Pasadena, CA15.8MShares$2.39 Billion1.62% of portfolio
-
Black Rock Inc. New York, NY14.5MShares$2.2 Billion0.08% of portfolio
-
State Street Corp Boston, MA7.47MShares$1.13 Billion0.04% of portfolio
-
Wellington Management Group LLP Boston, MA4.8MShares$727 Million0.11% of portfolio
About BIOGEN INC.
- Ticker BIIB
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 144,000,992
- Market Cap $21.8B
- Description
- Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...